Australia vs Iceland: Access to anti-retroviral drugs, female
Australia
87.0%
in 2023
Iceland
86.0%
in 2024
Australia rank
45th
Iceland rank
47th
Access to anti-retroviral drugs, female over time
- Australia
- Iceland
How they compare
Australia currently reports 87.0% against 86.0% in Iceland, a difference of 1.0%.
The two have swapped places 2 times across 24 shared years of data; in 2000 it was Australia ahead.
Australia ranks 45th and Iceland ranks 47th of 141 countries.
Iceland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Australia | Iceland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 51.7% | 63.4% | 11.7% | Iceland |
| 2010s | 66.4% | 84.0% | 17.6% | Iceland |
| 2020s | 81.5% | 83.0% | 1.5% | Iceland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Australia or Iceland?
- Australia, at 87.0% against 86.0% in Iceland as of 2023.
- What is the difference in access to anti-retroviral drugs, female between Australia and Iceland?
- 1.0%, with Australia ahead.
- How many years of comparable data are there for Australia and Iceland?
- 24 years are reported by both, from 2000 to 2023.
- How do Australia and Iceland rank globally for access to anti-retroviral drugs, female?
- Australia ranks 45th and Iceland ranks 47th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.